# Shenzhen Neoimmune Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-neoimmune-co

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Website: www.neoimmune.cn
- Latest round: Angel (Apr 23, 2020)
- Investors on record: 1

## About

Established in 2019 and based in Shenzhen, China, Shenzhen Nonimmune Co., Ltd. is a medical company that focuses on the development of key technologies for high-throughput reading and writing of T and B lymphocyte receptor profiles and their applications in clinical testing and treatment.

The company engages in the development of immune system disease detection and treatment products. Its main products include minimal residual disease (MRD) detection, FAIR-SEQ™ VJ multiple amplification library building kit and tumor immunotherapy, etc. Minimal Residual Disease (MRD) testing provides pre-treatment tumor sample testing services based on multiple amplification technology.

## Funding rounds

- Angel, Apr 23, 2020 — Oriza Holdings

## Investors

- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Angel